• Accueil >
  • Publications >
  • Immunogenicity and safety of influenza vaccination in cancer patients receiving checkpoint inhibitors targeting PD-1 or PD-L1

Immunogenicity and safety of influenza vaccination in cancer patients receiving checkpoint inhibitors targeting PD-1 or PD-L1

1 juil. 2020Annals of Oncology

DOI : 10.1016/j.annonc.2020.03.290

Auteurs

A. Bayle, M. Khettab, F. Lucibello, A.N. Chamseddine, V. Goldschmidt, A. Perret, S. Ropert, F. Scotté, P. Loulergue, O. Mir